There is a high probability that influencing the activity of the CX3CL1–CX3CR1 axis may also be beneficial in patients suffering from other diseases predisposing to dysglycemia (e.g., hyperadrenocorticism or chronic autoimmune and inflammatory diseases treated with corticosteroids). The gene discussed is CX3CL1; the disease is Cushing syndrome.